Niveau de preuve du suivi therapeutique pharmacologique de la ribavirine
Therapie, 66 3 (2011) 221-230
Published online: 2011-08-09
Articles citing this article
The Citing articles tool gives a list of articles citing the current article.
The citing articles come from EDP Sciences database, as well as other publishers participating in CrossRef Cited-by Linking Program. You can set up your personal account to receive an email alert each time this article is cited by a new article (see the menu on the right-hand side of the abstract page).
Cited article:
This article has been cited by the following article(s):
Novel and repurposed antiviral molecules for arbovirus infections with epidemic Potential: A systematic review
Jacopo Logiudice, Giorgio Tiecco, Alessandro Pavesi, Francesca Bertoni, Roberta Gerami, Isabella Zanella, Anna Artese, Francesco Castelli, Lina Rachele Tomasoni, Benedetta Rossi, Davide Lelli, Sabrina Canziani, Alessandro Russo, Guido Di Donato and Eugenia Quiros-RoldanNew Microbes and New Infections 66 101614 (2025)
https://doi.org/10.1016/j.nmni.2025.101614
Factors associated with DAA virological treatment failure and resistance-associated substitutions description in HIV/HCV coinfected patients
Dominique Salmon, Pascale Trimoulet, Camille Gilbert, et al.World Journal of Hepatology 10 (11) 856 (2018)
https://doi.org/10.4254/wjh.v10.i11.856
ITPA Deficiency and Ribavirin Level are Still Predictive of Anaemia in HCV–HIV-Coinfected Patients Receiving Ribavirin Combined with a First-Generation DAA (ANRS HC27 Study)
Farid Kheloufi, Isabelle Poizot-Martin, Rodolphe Garraffo, Aude Tavenard, Sylvie Quaranta, Alain Renault, Thibault Lavrut, Marc Bourlière, Philippe Halfon, Lionel Piroth, Eric Bellissant, Bruno Lacarelle, Jean-Michel Molina and Caroline SolasAntiviral Therapy 22 (6) 461 (2017)
https://doi.org/10.3851/IMP3074
Ribavirin at the Era of Novel Direct Antiviral Agents for the Treatment of Hepatitis C Virus Infection: Relevance of Pharmacological Monitoring
Pierre Pradat, Victor Virlogeux, Marie-Claude Gagnieu, Fabien Zoulim and François BaillyAdvances in Hepatology 2014 1 (2014)
https://doi.org/10.1155/2014/493087
Multiplex Liquid Chromatography-Tandem Mass Spectrometry Assay for Simultaneous Therapeutic Drug Monitoring of Ribavirin, Boceprevir, and Telaprevir
Manel Aouri, Darius Moradpour, Matthias Cavassini, Thomas Mercier, Thierry Buclin, Chantal Csajka, Amalio Telenti, Andri Rauch and Laurent A. DecosterdAntimicrobial Agents and Chemotherapy 57 (7) 3147 (2013)
https://doi.org/10.1128/AAC.00281-13
Ribavirin and abacavir drug interaction in HIV–HCV coinfected patients
Caroline Solas, Elodie Pambrun, Maria Winnock, et al.AIDS 26 (17) 2193 (2012)
https://doi.org/10.1097/QAD.0b013e32835763a4